Table II.

Women's Health Questionnaire and SF-36 health-related quality-of-life scores among the intervention and control groups—6 month intervention scores and change from base-line to end.

	End intervention	Control	Pa	Change intervention	Control	Pa
Health-related quality of life
SF-36 physical component score
Physical functioning	89.0 (13.5)	87.1 (14.8)	0.33	2.67 (10.8)	–0.64 (9.38)	0.049
Role–physical	81.4 (29.3)	77.3 (33.5)	0.48	5.14 (27.9)	–3.95 (30.0)	0.017
Bodily pain	69.4 (21.1)	70.2 (24.9)	0.65	0.72 (19.0)	–3.08 (21.4)	0.32
General health	66.9 (21.1)	65.1 (20.0)	0.55	3.01 (12.3)	–0.45 (12.1)	0.065
SF-36 mental component score
Vitality	66.9 (18.9)	58.3 (23.8)	0.023	5.72 (14.2)	–0.13 (16.3)	0.062
Social functioning	86.0 (19.6)	79.9 (25.1)	0.17	3.25 (19.1)	1.62 (20.9)	0.82
Role–emotional	85.6 (27.1)	78.4 (31.9)	0.12	6.85 (25.4)	3.07 (34.9)	0.46
Mental health	78.1 (15.9)	72.7 (17.6)	0.021	3.51 (11.9)	0.25 (13.2)	0.097
Menopause-specific quality of life score (WHQ)
Depressed mood	0.12 (0.20)	0.22 (0.21)	<0.001	–0.07 (0.16)	–0.02 (0.15)	0.023
Somatic symptoms	0.42 (0.30)	0.41 (0.26)	0.96	–0.04 (0.23)	–0.02 (0.17)	0.64
Memory/concentration	0.49 (0.35)	0.50 (0.38)	0.84	–0.03 (0.30)	–0.07 (0.34)	0.53
Vasomotor symptoms	0.83 (0.32)	0.85 (0.28)	0.92	–0.10 (0.37)	–0.05 (0.25)	0.30
Anxiety/fears	0.17 (0.26)	0.19 (0.22)	0.25	–0.04 (0.16)	–0.02 (0.17)	0.82
Sexual behaviour	0.38 (0.35)	0.43 (0.34)	0.39	–0.02 (0.27)	–0.02 (0.24)	0.94
Sleep problems	0.37 (0.33)	0.45 (0.30)	0.072	–0.08 (0.28)	–0.05 (0.26)	0.28
Menstrual symptoms	0.26 (0.29)	0.31 (0.32)	0.32	–0.08 (0.25)	–0.05 (0.29)	0.47
Attractiveness	0.17 (0.30)	0.30 (0.39)	0.041	–0.10 (0.31)	–0.01 (0.28)	0.062

^aP for difference between the groups; Mann—Whitney test.